DCF — MONTEFIORE MEDICAL CENTER
Enterprise Value: $-2.7B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.7B
Enterprise Value
$-891.6M
PV of Cash Flows
$-1.8B
PV of Terminal Value
$-2.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.1B | $-139.7M | -5.0% | $-271.1M | $-246.4M |
| Year 2 | $3.2B | $-111.9M | -4.0% | $-247.2M | $-204.3M |
| Year 3 | $3.3B | $-82.3M | -3.0% | $-221.7M | $-166.6M |
| Year 4 | $3.4B | $-67.8M | -2.0% | $-211.4M | $-144.4M |
| Year 5 | $3.5B | $-61.1M | -2.0% | $-209.0M | $-129.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.7B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5